Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 46-1473917 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To promote the use of progenitor/stem cells and other cellular therapies in the treatment of disease, traumatic injury and chronic pain; to provide education related to this type of medical treatment and therapies; to maintain and promote laboratory practice and clincial guidelines related to this type of medical treatment and therapies; and to design and manage an accreditation program to evaluate clinics and facilities that provide these types of medical treatments and therapies.
Principal Officer
Elliot Lander MD
Total Revenue
$319K
FY2024
Total Expenses
$317K
FY2024
Net Assets
-$228K
Program Ratio
97.6%
expenses on programs
Employees
0
Volunteers
—
Board Members
1
Voting
1
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.